Department of Surgery, Ankara Oncology Hospital, 12/34 Cukurambar, Ankara, Turkey.
Clin Breast Cancer. 2011 Dec;11(6):395-9. doi: 10.1016/j.clbc.2011.08.001. Epub 2011 Oct 10.
This study was planned to investigate the early postoperative complications of reduction mammoplasty done for benign or malignant reasons on 286 patients. Minor and major complication rates were 16.3% and 1.9%, respectively.There was no significant difference in terms of complications between the patients with and those without breast cancer. Body mass index was found to be the only factor associated with the complication rates.
This study was planned to investigate the early postoperative complications after reduction mammoplasty applied either for benign or malignant reasons and reliability of the technique with respect to wound healing.
Two hundred and eighty-six reduction procedures were evaluated prospectively. Fifty-two patients underwent reduction mammoplasty for macromastia and 101 for macromastia with breast cancer. The wound complications were evaluated in 2 groups, as minor and major complications. Seroma, hematoma, surgical site infection, delayed wound healing, and minor wound dehiscence were included in the minor complication group. Severe complications, such as necrosis of nipple-areola complex and major incisional wound dehiscence, were included in the major complications group.
Mean (SD) age of the patients was 48.8 ± 10.3 years, mean (SD) body mass index was 29 ± 3.3 kg/m(2), and mean (SD) weight of resected specimen was 958 ± 72 g. Mean (SD) preoperative and postoperative volumes for each breast were 1245 ± 75 cm(3) and 436 ± 27 cm(3), respectively. Minor and major complication rates were 25/153 (16.3%) and 3/153 (1.9%), respectively. There was no significant difference in terms of complications between the patients with and without breast cancer. Body mass index was found to be the only factor associated with the complication rates.
Reduction mammoplasty is a surgical technique that has satisfactory cosmetic results in the treatment of macromastia. This technique also is safe in the treatment of breast cancer patients with macromastia and does not increase complication rates.
本研究旨在调查因良性或恶性原因行缩乳术的 286 例患者的早期术后并发症。轻微和严重并发症的发生率分别为 16.3%和 1.9%。良性和恶性肿瘤患者的并发症发生率无显著差异。体重指数是唯一与并发症发生率相关的因素。
本研究旨在调查因良性或恶性原因行缩乳术的早期术后并发症，并评估该技术在伤口愈合方面的可靠性。
前瞻性评估了 286 例缩乳术。52 例患者因巨乳症而行缩乳术，101 例患者因巨乳症合并乳腺癌而行缩乳术。将伤口并发症评估为轻微和严重并发症。血清肿、血肿、手术部位感染、伤口愈合延迟和轻微伤口裂开属于轻微并发症组。乳头乳晕复合体坏死和严重切口裂开等严重并发症属于严重并发症组。
患者的平均（标准差）年龄为 48.8±10.3 岁，平均（标准差）体重指数为 29±3.3kg/m²，切除标本的平均（标准差）重量为 958±72g。每个乳房的术前和术后平均（标准差）体积分别为 1245±75cm³和 436±27cm³。轻微和严重并发症的发生率分别为 25/153（16.3%）和 3/153（1.9%）。良性和恶性肿瘤患者的并发症发生率无显著差异。体重指数是唯一与并发症发生率相关的因素。
缩乳术是一种治疗巨乳症的手术技术，具有良好的美容效果。对于合并巨乳症的乳腺癌患者，该技术也是安全的，不会增加并发症发生率。
